logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10835572 B1

PDFFull Text
Date of Patent:
Nov. 17, 2020

Filed:

Jun. 30, 2015

Composition for external application

Applicant:

Rohto Pharmaceutical Co., Ltd., Osaka, JP;

Inventors:

Masatoshi Haga, Osaka, JP;

Keiko Oyamada, Osaka, JP;

Rumi Matsushita, Osaka, JP;

Yuya Hayashi, Osaka, JP;

Kyoko Nakajima, Osaka, JP;

Yuko Kouda, Osaka, JP;

Assignee:

ROHTO PHARMACEUTICAL CO., LTD., Osaka, JP;

Attorney:

Riverside Law LLP

Primary Examiner:

Benjamin J Packard

Int. Cl.
CPC ...
A61K 8/44 (2006.01); A61K 38/05 (2006.01); A61K 9/08 (2006.01); A61K 31/7034 (2006.01); A61Q 17/04 (2006.01); A61K 31/506 (2006.01); A61K 8/49 (2006.01); A61K 31/122 (2006.01); A61K 31/12 (2006.01); A61K 8/64 (2006.01); A61K 8/34 (2006.01); A61K 8/67 (2006.01); A61K 9/00 (2006.01); A61K 31/045 (2006.01); A61K 31/375 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01); A61Q 11/00 (2006.01); A61Q 15/00 (2006.01); A61Q 19/08 (2006.01);
U.S. Cl.
CPC ...
A61K 38/05 (2013.01); A61K 8/34 (2013.01); A61K 8/44 (2013.01); A61K 8/4946 (2013.01); A61K 8/64 (2013.01); A61K 8/676 (2013.01); A61K 9/0014 (2013.01); A61K 9/0048 (2013.01); A61K 9/08 (2013.01); A61K 31/045 (2013.01); A61K 31/12 (2013.01); A61K 31/122 (2013.01); A61K 31/375 (2013.01); A61K 31/506 (2013.01); A61K 31/7034 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61Q 11/00 (2013.01); A61Q 15/00 (2013.01); A61Q 17/04 (2013.01); A61Q 19/08 (2013.01);
Abstract

An object of the present invention is to provide an external use composition having a novel composition that has a superior effect promoting collagen production and is able to suppress, prevent or improve wrinkles and sagging of the skin with aging. The present invention relates to an external use composition for anti-aging, comprising (A) a lipopeptide represented by the following formula (1), or a pharmaceutically acceptable salt thereof: (wherein, Rrepresents a saturated aliphatic group, or aliphatic group having a single unsaturated bond, having 9 to 19 carbon atoms, and m represents 0 or 1).

Find Patent Forward Citations

Loading…